TFC Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72K Sell
1,250
-82
-6% -$4.71K 0.01% 255
2026
Q1
$80.8K Sell
1,332
-1,100
-45% -$64.1K 0.01% 223
2025
Q4
$131K Hold
2,432
0.02% 172
2025
Q3
$110K Sell
2,432
-238
-9% -$11.1K 0.01% 186
2025
Q2
$124K Sell
2,670
-15
-0.6% -$736 0.02% 171
2025
Q1
$164K Buy
2,685
+7
+0.3% +$408 0.03% 138
2024
Q4
$151K Buy
2,678
+25
+0.9% +$1.4K 0.02% 149
2024
Q3
$137K Buy
2,653
+30
+1% +$1.41K 0.02% 160
2024
Q2
$109K Sell
2,623
-27
-1% -$1.21K 0.02% 160
2024
Q1
$144K Sell
2,650
-55
-2% -$2.8K 0.03% 145
2023
Q4
$139K Sell
2,705
-19
-0.7% -$997 0.03% 148
2023
Q3
$158K Buy
2,724
+8
+0.3% +$490 0.04% 127
2023
Q2
$174K Buy
2,716
+436
+19% +$29.2K 0.04% 122
2023
Q1
$158K Buy
2,280
+31
+1% +$2.19K 0.04% 125
2022
Q4
$162K Buy
2,249
+2
+0.1% +$151 0.05% 109
2022
Q3
$160K Hold
2,247
0.05% 104
2022
Q2
$173K Hold
2,247
0.05% 104
2022
Q1
$164K Hold
2,247
0.05% 116
2021
Q4
$140K Sell
2,247
-1,820
-45% -$107K 0.04% 131
2021
Q3
$241K Hold
4,067
0.08% 84
2021
Q2
$272K Hold
4,067
0.09% 75
2021
Q1
$257K Hold
4,067
0.1% 76
2020
Q4
$252K Hold
4,067
0.11% 77
2020
Q3
$245K Buy
+4,067
New +$245K 0.12% 70

Other funds holding BMY

TFC Financial Management's BMY Position: Q2 2026 in Review

TFC Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q2 2026, selling an estimated $4.71K and leaving 1,250 shares worth $72K. The position accounts for 0.01% of the portfolio, ranked #255.

TFC Financial Management first reported a position in BMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $272K in Q2 2021. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • TFC Financial Management held 1,250 shares of Bristol-Myers Squibb worth $72K as of Q2 2026.
  • TFC Financial Management sold 82 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.71K.
  • Bristol-Myers Squibb made up 0.01% of TFC Financial Management's portfolio in Q2 2026, its #255 holding.
  • TFC Financial Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 24 quarters since.
  • TFC Financial Management's Bristol-Myers Squibb position peaked at $272K in Q2 2021.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.